Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Medical treatments of elderly, French patients with type 2 diabetes: results at inclusion in the GERODIAB Cohort.

Doucet JA, Bauduceau B, Le Floch JP, Verny C; SFD/SFGG Intergroup.

Fundam Clin Pharmacol. 2016 Feb;30(1):76-81. doi: 10.1111/fcp.12160. Epub 2015 Nov 8.

PMID:
26478566
2.

Orthostatic hypotension is associated with more severe hypertension in elderly autonomous diabetic patients from the French Gerodiab study at inclusion.

Bouhanick B, Meliani S, Doucet J, Bauduceau B, Verny C, Chamontin B, Le Floch JP; Gerodiab Study Group.

Ann Cardiol Angeiol (Paris). 2014 Jun;63(3):176-82. doi: 10.1016/j.ancard.2014.05.013. Epub 2014 Jun 7.

PMID:
24958527
3.

Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected].

Busiah K, Drunat S, Vaivre-Douret L, Bonnefond A, Simon A, Flechtner I, Gérard B, Pouvreau N, Elie C, Nimri R, De Vries L, Tubiana-Rufi N, Metz C, Bertrand AM, Nivot-Adamiak S, de Kerdanet M, Stuckens C, Jennane F, Souchon PF, Le Tallec C, Désirée C, Pereira S, Dechaume A, Robert JJ, Phillip M, Scharfmann R, Czernichow P, Froguel P, Vaxillaire M, Polak M, Cavé H; French NDM study group.

Lancet Diabetes Endocrinol. 2013 Nov;1(3):199-207. doi: 10.1016/S2213-8587(13)70059-7. Epub 2013 Sep 6. Erratum in: Lancet Diabetes Endocrinol. 2013 Nov;1(3):e14.

PMID:
24622368
4.

Cardiovascular events and geriatric scale scores in elderly (70 years old and above) type 2 diabetic patients at inclusion in the GERODIAB cohort.

Bauduceau B, Doucet J, Le Floch JP, Verny C; SFD/SFGG Intergroup and the GERODIAB Group.

Diabetes Care. 2014;37(1):304-11. doi: 10.2337/dc13-1540. Epub 2013 Aug 29.

PMID:
23990512
5.

GERODIAB: Glycaemic control and 5-year morbidity/mortality of type 2 diabetic patients aged 70 years and older: 1. Description of the population at inclusion.

Doucet J, Le Floch JP, Bauduceau B, Verny C; SFD/SFGG Intergroup.

Diabetes Metab. 2012 Dec;38(6):523-30. doi: 10.1016/j.diabet.2012.07.001. Epub 2012 Oct 10.

PMID:
23062595
6.

Non-inferiority of insulin glargine versus insulin detemir on blood glucose variability in type 1 diabetes patients: a multicenter, randomized, crossover study.

Renard E, Dubois-Laforgue D, Guerci B; Variability Study Group.

Diabetes Technol Ther. 2011 Dec;13(12):1213-8. doi: 10.1089/dia.2011.0063. Epub 2011 Aug 2.

PMID:
21810024
7.

Multicentre evaluation of the DCA 2000 system for measuring glycated haemoglobin. DCA 2000 Study Group.

Guerci B, Durain D, Leblanc H, Rouland JC, Passa P, Godeau T, Charbonnel B, Mathieu Daude JC, Boniface H, Monnier L, Dauchy F, Slama G, Drouin P.

Diabetes Metab. 1997 Jun;23(3):195-201.

PMID:
9233995
8.

[Current data on the physiopathology of massive obesity].

Godeau T, Krempf M.

Rev Prat. 1993 Oct 1;43(15):1895-9. French.

PMID:
7906052
9.

[Insulin resistance and arterial hypertension].

Godeau T, Blanchard P, Krempf M.

Ann Med Interne (Paris). 1993;144(4):260-6. Review. French. No abstract available.

PMID:
8368719
10.

[Endocrinology of impotence].

Godeau T, Charbonnel B.

Journ Annu Diabetol Hotel Dieu. 1993:315-29. Review. French. No abstract available.

PMID:
8331872
11.

[Oral and dietary treatments of type 2 diabetes].

Godeau T, Charbonnel B.

Rev Prat. 1992 May 1;42(9):1093-8. Review. French.

PMID:
1496236
12.
13.

Class II MHC antigen induction on rat insulinoma (RINm5F) and colon carcinoma (TS) cells by co-culture with diabetic and normal xenogenic lymphocytes.

Maugendre D, Godeau T, Feve B, Segain JP, Valentin A, Sai P, Houssaint E.

J Autoimmun. 1989 Jun;2(3):229-40.

PMID:
2765097

Supplemental Content

Loading ...
Support Center